Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.

MLA

Gupta, Yask, et al. “Strong Protective Effect of the APOL1 p.N264K Variant against G2-Associated Focal Segmental Glomerulosclerosis and Kidney Disease.” Nature Communications, vol. 14, no. 1, Nov. 2023, p. 7836. EBSCOhost, https://doi.org/10.1038/s41467-023-43020-9.

APA

Gupta, Y., Friedman, D. J., McNulty, M. T., Khan, A., Lane, B., Wang, C., Ke, J., Jin, G., Wooden, B., Knob, A. L., Lim, T. Y., Appel, G. B., Huggins, K., Liu, L., Mitrotti, A., Stangl, M. C., Bomback, A., Westland, R., Bodria, M., … Sanna-Cherchi, S. (2023). Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease. Nature Communications, 14(1), 7836. https://doi.org/10.1038/s41467-023-43020-9

Chicago

Gupta, Yask, David J Friedman, Michelle T McNulty, Atlas Khan, Brandon Lane, Chen Wang, Juntao Ke, et al. 2023. “Strong Protective Effect of the APOL1 p.N264K Variant against G2-Associated Focal Segmental Glomerulosclerosis and Kidney Disease.” Nature Communications 14 (1): 7836. doi:10.1038/s41467-023-43020-9.